We are pleased to announce that Medical Mycology new impact factor is 4.076. Many thanks to our past and present Chief Editors, Karl Clemons and Sharon Chen, members of the editorial board and reviewers!
It now ranks #5 of 29 journals in the Mycology category, #19 of 117 journals in the Infectious Diseases category, and #21 of 166 journals in the Veterinary Sciences category. (By comparison, last year’s IF was 2.822, and it ranked #13 of 29 journals in the Mycology category, #47 of 93 journals in the Infectious Diseases category, and #8 of 142 journals in the Veterinary Sciences category.)
Prof Alexandro Bonifaz and Prof Flavio de Quieroz-Tellez are developing a Special issue on Neglected Implantation Mycoses in Medical Mycology Case reports. Call for papers is now open. This Special issue of will publish peer-reviewed case-reports and small case-series related to the endemic implantation mycoses of human and veterinary relevance. Further information can be found in the link: https://www.journals.elsevier.com/medical-mycology-case-reports/call-for-papers/neglected-implantation-mycoses
Dr Jill Adler-Moore, 76 years old, passed away on June 14, 2021 at 9:40pm, at home and surrounded by her family.
Amongst many other accolades Jill was instrumental in the development of liposomal amphotericin B. A full obituary will follow later.
The deadline for NIAF's inaugural Fauci Fellowships is rapidly approaching. In recognition of Dr. Anthony S. Fauci's life saving work, NIAF will award two $50,000 post-doctoral research grants—one to an Italian researcher working in Italy, and the other to an Italian American researcher working in the United States—to support research in infectious diseases and help establish the recipients' independent careers. Preference will be given to applicants who have earned their Ph.D. in an eligible field in the past eight years.
Link to THE NATIONAL ITALIAN AMERICAN FOUNDATION
The Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology was released on February 16, 2021.
This is the second guideline of the One World – One Guideline initiative intending to diagnose these devastating diseases earlier, and to lead to more rapid and targeted treatment initiation.
45 experts from 24 countries developed this guidance document. Upon today‘s publication in Lancet Infectious Diseases, the guideline was endorsed by 55 scientific societies from around the world.
Here is a link to the publishes article on The Lancet website: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30784-2/fulltext and a link under which the guideline can be downloaded for free for the next 50 days https://authors.elsevier.com/a/1cbR25E-UoSQg2
Hoenigl, M., Salmanton-García, J., Walsh, T. J., Nucci, M., Neoh, C. F., Jenks, J. D., et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. The Lancet Infectious Diseases. 2021 doi:10.1016/S1473-3099(20)30784-2
The obituary of Professor William Merz is published in the Mycological Heroes section of this website
We have an available Post-Doctoral Scientist Position in our laboratory at NIH to study ‘Genomic Diversity, Pathobiology, and Antifungal Susceptibility/Resistance of Emerging and Cryptic Aspergillus Species Isolated from Hospitalized Patients with Underlying Immunodeficiencies.’
This post will be available until February 14, 2021 or until filled.
The NIH is dedicated to building a diverse community in its training and employment programs.
The obituary of Professor Harbans Singh Randhawa is published in the Mycological Heroes section of this website
November 2, 2020
ISHAM is pleased to announce Sharon Chen, Director of the Centre for Infectious Diseases and Microbiology Laboratory Services at Westmeade Hospital in Sydney, Australia, as the incoming Editor-in-Chief of its flagship journal, Medical Mycology. Dr. Chen’s appointment will begin January 2021.
ISHAM thanks Karl V Clemons, the present Editor-in-Chief for his immense contribution to Medical Mycology. He has uplifted the quality of the journal to a new standard. He will complete his term in December 2020.
Dr. Arunaloke Chakrabarti, MD
President, International Society for Human and Animal Mycology
June 23, 2020
It gives us great pleasure to announce the recipient of the 2019 Ira F. Salkin award for the best paper published in Medical Mycology by a member of YISHAM. This award made possible by the family of Dr. Salkin (a previous Editor in Chief of Medical Mycology) is to encourage members of YISHAM to begin their careers in science with quality publications.
The recipient of the 2019 award is Ivan Mikhailovich Pchelin, MSc from the Laboratory of Molecular Genetic Microbiology at the Kashkin Research Institute of Medical Mycology, North-Western State Medical University in St. Petersburg, Russia. His article, Ivan M. Pchelin, Daniil V. Azarov, Maria A. Churina, Sergey G. Scherbak, Svetlana V. Apalko, Natalya V. Vasilyeva, and Anastasia E. Taraskina. Species boundaries in the Trichophyton mentagrophytes/T. interdigitale species complex. Medical Mycology, 2019, 57, 781–789 doi: 10.1093/mmy/myy115 was chosen by the awards committee as standing apart from the other nominations as the best embodiment of ISHAM’s mission, and contributions by our YISHAM members to the field of Medical Mycology. His article contributes to the improved clarity of the taxonomy of this important group of dermatophytes. We encourage you to read his paper.
Join us in congratulating Ivan this award. We will look forward to hearing Ivan present his paper at YISHAM day at the next ISHAM congress in New Delhi.
For the awards committee:
Karl V. Clemons, PhD
Editor in Chief
Chester R. Cooper, PhD
Malcolm D. Richardson, PhD
New videos by Dr Alessandro Pasqualotto and by Prof Oliver Cornely.
Mayne Pharma is seeking a Medical Science Liaison in infectious disease. If you are a Nurse, Nurse Practitioner, Physician Assistant, PharmD, PhD or MD who is looking to break into the pharmaceutical industry. This job description for the position can be found on our website at:
The essential part of this job will to have relationships in infectious disease with thought leaders in the endemic area and to have attended conferences over the years in cultivating these relationships. The emphasis does not have to be in fungal disease. Bacterial, viral, etc will qualify them as well.